College of Medicine, QU Health, Qatar University, Doha, Qatar.
College of Medicine, QU Health, Qatar University, Doha, Qatar; Department of Anaesthesiology, ICU, and Perioperative Medicine, Hazm Mebaireek General Hospital, Hamad Medical Corporation, Doha, Qatar.
Br J Anaesth. 2024 Jul;133(1):93-102. doi: 10.1016/j.bja.2024.03.022. Epub 2024 Apr 26.
Propofol and sevoflurane are two of the most commonly used anaesthetics for paediatric surgery. Data from some clinical trials suggest that postoperative pain incidence is lower when propofol is used for maintenance of anaesthesia compared with sevoflurane, although this is not clear.
This meta-analysis compared postoperative pain following maintenance of anaesthesia with propofol or sevoflurane in paediatric surgeries. PubMed Medline, Embase, Scopus, Web of Science and Cochrane Library were searched for randomised controlled trials (RCTs) that compared postoperative pain between sevoflurane and propofol anaesthesia in children. After quality assessment, a meta-analysis was carried out using bias-adjusted inverse heterogeneity methods, heterogeneity using I and publication bias using Doi plots.
In total, 13 RCTs with 1174 children were included. The overall synthesis suggested nearly two-fold higher odds of overall postoperative pain in the sevoflurane group compared with the propofol group (odds ratio [OR] 1.88, 95% confidence interval [CI] 1.12-3.15, I=58.2%). Further, children in the sevoflurane group had higher odds of having higher pain scores (OR 3.18, 95% CI 1.83-5.53, I=20.9%), and a 60% increase in the odds of requiring postoperative rescue analgesia compared with propofol (OR 1.60, 95% CI 0.89-2.88, I=58.2%).
Children maintained on inhalational sevoflurane had higher odds of postoperative pain compared with those maintained on propofol. The results also suggest that sevoflurane is associated with higher odds of needing postoperative rescue analgesia compared with propofol.
The protocol for this systematic review and meta-analysis was registered on the International Prospective Register of Systematic Reviews (PROSPERO) with registration ID CRD42023445913.
丙泊酚和七氟醚是小儿外科最常用的两种麻醉剂。一些临床试验的数据表明,与七氟醚相比,在维持麻醉时使用丙泊酚术后疼痛发生率较低,但这一点并不明确。
本荟萃分析比较了小儿手术中维持麻醉时使用丙泊酚或七氟醚的术后疼痛情况。通过检索 PubMed Medline、Embase、Scopus、Web of Science 和 Cochrane Library,寻找比较七氟醚和丙泊酚麻醉下儿童术后疼痛的随机对照试验(RCT)。经过质量评估,采用偏倚调整的异质性逆方差法进行荟萃分析,采用 I 检验和 Doi 图评估异质性和发表偏倚。
共纳入 13 项 RCT,涉及 1174 名儿童。总体综合结果表明,七氟醚组术后总体疼痛的可能性几乎是丙泊酚组的两倍(优势比 [OR] 1.88,95%置信区间 [CI] 1.12-3.15,I=58.2%)。此外,七氟醚组的儿童发生更高疼痛评分的可能性更高(OR 3.18,95% CI 1.83-5.53,I=20.9%),与丙泊酚相比,需要术后补救镇痛的可能性增加 60%(OR 1.60,95% CI 0.89-2.88,I=58.2%)。
与维持丙泊酚相比,维持吸入七氟醚的儿童术后疼痛的可能性更高。结果还表明,与丙泊酚相比,七氟醚与更高的术后需要补救镇痛的可能性相关。
本系统评价和荟萃分析的方案在国际前瞻性注册系统评价(PROSPERO)上注册,注册 ID 为 CRD42023445913。